| Next 10 |
Ad
ADRO News and Press Aduro Biotech Inc.
-
Combined Company Will H ave Over $275 Million in Operating Capital and Trade on Nasdaq under the Ticker Symbol “KDNY” VANCOUVER, British Columbia and SEATTLE, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Chinook Therap...
-
Gainers: Aduro Biotech (ADRO) +442%, American Renal Associates (ARA) +69%, Nano-X Imaging (NNOX) +38%, CTI BioPharma (CTIC) +18%, ProPhase Labs (PRPH) +16%.Losers: Benitec Biopharma (BNTC) -36%, Mesoblast (MESO) -36%, Arcutis Biotherapeut...
-
One-for-Five Reverse Stock Split to be Effective October 2, 2020 BERKELEY, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADURO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (ST...
-
Analysts Have High Hopes For These Penny Stocks When it comes to penny stocks , they’re a dime a dozen. There are thousands of stocks under $5 to choose from. The biggest thing traders focus on is how to make money with penny stocks quickly . That’s one of the ...
-
Gainers: MICT (NASDAQ: MICT ) +52% . More news on: MICT, Inc., RISE Education Cayman Ltd, Forward Industries, Inc., Stocks on the move, , Read more ...
-
Aduro Biotech (NASDAQ: ADRO ) : Q2 GAAP EPS of -$0.21 misses by $0.02 . More news on: Aduro Biotech, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
-
BERKELEY, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the A Proliferation Inducing Ligand (APRIL) and Stimulator of Interferon Genes (STING) pathways for the treatment of c...
-
Aduro Biotech (NASDAQ: ADRO ) doses first patient with IgA nephropathy in a Phase 1 clinical trial of BION-1301 , an investigational humanized IgG4 monoclonal antibody. More news on: Aduro Biotech, Inc., Healthcare stocks news, Read more ...
-
BERKELEY, Calif., June 24, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand (APRIL) pathways for the treatment of c...
-
Gainers: Ameri Holdings (NASDAQ: AMRH ) +152% . More news on: Ameri Holdings, Inc., Westwater Resources, Inc., Genius Brands International, Inc., Stocks on the move, , Read more ...
Stock Information
Aduro Biotech Inc. Company Name:
ADRO Stock Symbol:
NASDAQ Market:
Get ADRO Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
